Autoimmune lpr/lpr mice deficient in CD40 ligand: Spontaneous Ig class switching with dichotomy of autoantibody responses

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 417-426

  Ma, Jian ^a   Xu, Jianchao ^a   Madaio, Michael P ^b   Peng, Qingshuang ^a   Zhang, Jean ^a   Grewal, Iqbal S ^a   Flavell, Richard A ^a   Craft, Joe ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Section of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD40 ANTIGEN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; SMALL NUCLEAR RNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; GLOMERULONEPHRITIS; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, CD40; AUTOANTIBODIES; BASE SEQUENCE; CD40 LIGAND; CROSSES, GENETIC; GLOMERULONEPHRITIS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIGANDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA;

EID: 0029939451     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
2. Watanabe-Fukunaga, R., C. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
3. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
4. Wu, J., T. Zhou, J. He, and J. D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461.
5. Chu, J.-L., J. Drappa, A. Parnassa, and K. Elkon. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon ETn. J. Exp. Med. 178:723.
6. Izui, S., V. E. Kelley, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
7. Warren, R. W., S. A. Caster, J. B. Roths, E. D. Murphy, and D. S. Pisetsky. 1984. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin. Immunol. Immunopathol. 31:65.
8. Kelley, V. E., and J. B. Roths. 1985. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37:220.
9. Shlomchik, M. J., M. P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180:1295.
10. Seaman, W. E., D. Wofsy, J. S. Greenspan, and J. A. Ledbetter. 1983. Treatment of autoimmune MRL/lpr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease. J. Immunol. 130:1713.
11. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167:1713.
12. Jabs, D. A., C. Burek, Q. Hu, R. Kuppers, B. Lee, and R. Prendergast. 1992. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/ Mp-lpr/lpr mice. Cell. Immunol. 141:496.
13. 1 and MRL/MpJ lpr/lpr mice. J. Immunol. 151:6509.
14. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179:1137.
15. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, E. A. Clark, C. A. Smith, K. H. Grabstein, D. Cosman, and M. K. Spriggs. 1992. Molecular and biological characterization of the murine ligand for CD40. Nature 357:80.
16. Fanslow, W. C., D. Anderson, K. H. Grabstein, E. A. Clark, D. Cosman, and R. J. Armitage. 1992. Soluble forms of CD40 inhibit biological responses of human B cells. J. Immunol. 149:655.
17. Hollenbaugh, D., L. S. Grosmaire, C. D. Kullas, N. J. Chalupny, S. Braesch-Anderson, R. J. Noelle, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11:4313.
18. Lederman, S., M. J. Yellin, G. Inghirami, J. J. Lee, D. M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 48:3817.
19. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
20. Spriggs, M. K., R. J. Armitage, L. Strockbine, K. N. Clifford, B. M. Macduff, T. A. Sato, C. R. Maliszewski, and W. C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543.
21. Lane, P., A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-assocated antigen CD40 which participates in T cell-dependendent activation of B lymphocytes. Eur. J. Immunol. 177:1209.
22. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simonequx, W. C. Fanslow, J. Belmont, and M. K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
23. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosmaire, R. Stenkamp, and M. Neubaier. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.
24. Disanto, J. P., J. F. Bonnefoy, J. F. Gauchel, A. Fischer, and G. de Saint Basile. 1993. CD40L ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541.
25. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R. S. Rosen, T. Chatila, S. M. Fu, I. Stamenkovic, and R. S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90:2170.
26. Korthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539.
27. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
28. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
29. Renshaw, B. R., W. C. Fanslow III, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889.
30. Castigli, E., F. W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A. K. Bhan, and R. S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91:12135.
31. MacLennan, I. C. M. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.
32. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
33. Durie, F. H., A. Aruffo, J. Ledbetter, K. M. Crassi, W. R. Green, L. D. Fast, and R. J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333.
34. Morris, S. C., R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1990. Autoantibodies in chronic GVH result in cognate T-B interactions. J. Exp. Med. 171:503.
35. Kuwana, M., T. A. Medsger, Jr., and T. M. Wright. 1995. T and B cells collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J. Immunol. 155:2703.
36. Hughes, D. P. M., A. Hayday, J. E. Craft, M. J. Owen, and I. N. Crispe. 1995. T cells with γ 47 δ T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-α-deficient lpr mice. J. Exp. Med. 182:233.
37. Fatenejad, S., M. Mamula, and J. Craft. 1993. Role of intrastructural B and T cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90:12010.
38. Rubin, R. L. 1992. Enzyme-linked immunosorbent assay for anti-DNA and antihistone antibodies including anti-(H2A-H2B). In Manual of Clinical Laboratory Immunology, 4th Ed. N. R. Rose, E. C. DeMacario, J. L. Fathey, H. Friedman, and G. M. Penn, eds. American Society for Microbiology, Washington, DC, p. 735.
39. Cook, L., and V. Agnello. 1992. Tests for detection of rheumatoid factor. In Manual of Clinical Laboratory Immunology, 4th Ed. N. R. Rose, E. C. DeMacario, J. L. Fathey, H. Friedman, and G. M. Penn, eds. American Society for Microbiology, Washington, DC, p. 762.
40. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350.
41. Craft, J., T. Mimori, T. Olsen, and J. Hardin. 1988. The U2 small nuclear ribonucleoprotein particle as an autoantigen. J. Clin. Invest. 81:1716.
42. Vlahakos, D. V., M. H. Foster, S. Adams, M. Katz, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio. 1992. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 41:1690.
43. Vlahakos, D., M. H. Foster, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2:1345.
44. Klinman, D., and A. D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol. Rev. 144:156.
45. Hewicker, M., and G. Trautwein. 1986. Glomerular lesions in MRL mice: a light and immunofluorescence study. J. Vet. Med. B. 33:727.
46. Buyon, J. P. 1992. Neonatal lupus syndromes. In Systemic Lupus Erythematosus, 2nd Ed. R. G. Lahita, ed. Churchill Livingstone, New York, p. 419.
47. Foy, M. T., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.
48. Han, S., K. Hathcock, B. Zheng, T. B. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers: roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556.
49. Notarangelo, L. D., M. Duse, and A. G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodef. Rev. 3:101.
50. Jacobsen, B. A., D. J. Panka, K.-A. Nguyen, J. Erikson, A. A. Abbas, and A. Marshak-Rothstein. 1995. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3:509.
51. Burlingame, R. W., R. L. Rubin, R. S. Balderas, and A. N. Theofilopoulos. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1687.
52. Sobel, E. S., V. N. Kakkanaiah, M. Kakkanaiah, R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1994. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol. 152:6011.
53. Hahn, B. H., and B. P. Tsao. 1993. Antibodies in DNA. In Dubois' Lupus Erythematosus, 4th Ed. D. J. Wallace and B. H. Hahn, eds. Lea & Febinger, Philadelphia, PA, p. 195.
54. Sobel, E. S., P. L. Cohen, and R. A. Eisenberg. 1993. lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 150:4160.
55. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441.
56. Perkins, D. L., R. M. Glaser, C. A. Mahon, J. Michaelson, and A. Marshak-Rothstein. 1990. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 145:549.
57. Nemazee, D., C. Guiet, K. Buerki, and A. Marshak-Rothstein. 1991. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr-DBA/2 chimeras. J. Immunol. 147:2536.
58. Craft, J. 1992. Antibodies to snRNPs in SLE. Rheumat. Dis. Clin. 18:311.
59. Mamula, M. J., S. Fatenejad, and J. Craft. 1994. B cell process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152:1453.
60. Hoffman, R. W., Y. Takeda, G. C. Sharp, D. R. Lee, D. L. Hill, H. Kaneoka, and C. W. Caldwell. 1993. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J. Immunol. 151:6460.
61. Okubo, M., K. Yamamoto, T. Kato, N. Matsuura, T. Nishmaki, R. Kasukawa, K. Ito, Y. Mizushima, and K. Nishioka. 1993. Detection and epitope analysis of autoantigen-reactive T cells to small nuclear ribonucleoprotein A protein in autoimmune disease patients. J. Immunol. 151:1108.
62. Bloom, D. D., J. Davignon, M. W. Retter, M. J. Shlomchik, D. S. Pisetsky, P. L. Cohen, R. A. Eisenberg, and S. H. Clarke. 1993. V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J. Immunol. 150:1591.
63. Lane, P., C. Burdet, F. McConnell, A. Lanzavecchia, and E. Padovan. 1995. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 25:1788.
64. Macchia, D., F. Almerigogna, P. Parronchi, A. Ravina, E. Maggi, and S. Romagnani. 1993. Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 363:464.
65. Agematsu, K., T. Kobata, K. Sugita, G. J. Freeman, M. P. Beckmann, S. F. Schlossman, and C. Morimoto. 1994. Role of CD27 in T cell immune response: analysis by recombinant soluble CD27. J. Immunol. 153:1421.
66. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655.
67. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317.
68. Shan, H., M. J. Shlomchik, A. Marshak-Rothstein, D. S. Pisetsky, S. Litwin, and M. G. Weigert. 1994. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153:5104.
69. Bloom, D. D., J.-L. Davignon, P. L. Cohen, R. A. Eisenberg, and S. L. Clarke. 1993. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J. Immunol. 150:1579.